NCT04022785: PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
|
|
| Completed | 1 | 43 | US | Azacitidine, 5 AZC, 5-AC, 5-Azacytidine, 5-AZC, Azacytidine, Azacytidine, 5-, Ladakamycin, Mylosar, U-18496, Vidaza, BRD4 Inhibitor PLX51107, PLX 51107, PLX-51107, PLX51107 | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Myeloproliferative Neoplasm | 10/22 | 10/22 | | |
